Thursday, March 31, 2022

Gliadin IgA, IgG antibodies, serum

Erased test 

Test code: 

856 -Gliadin IgA antibodies, serum

Nemonic code: AGLIA

2086 - Gliadin IgG antibodies, serum

Nemonic code AGLIG

Alternative:

1236-  GLIADIN DEAMINATION IgA ANTIBODIES, SERUM  

Nemonic code: AGLIDA

1237-  GLIADIN DEAMINATION IgG ANTIBODIES, SERUM 

 Nemonic code: AGLIDG

Effective update from 04/04/2022



Notice: Sample Restrictions Easter Holidays

Sample Restrictions Easter Holidays

 

Dear valued colleagues and customers,

Please kindly note the following festivity restrictions at the central laboratory of Barcelona during Easter Holiday:

- Customer Service will offer service from 8 a.m. to 10 p.m from Thursday April 14th to Monday, April 18th.

- As for the reception and processing of the samples of SARS-CoV-2 PCR, we will offer service every day, thus maintaining the usual deadline for delivering results in 24 hours.

We inform you that special collection services for PCR can be requested in advance on those days, always after consulting with their sales representative assigned for assessment together with logistics department.

- For the reception and processing o clinical analysis samples, we will not offer service during the days 15th, 17th and 18th of April, therefore, TAT can be affected.

Be informed of the following additional restrictions aimed at preserving the stability of samples during these days:

Test

Non-acceptance days

(both inclusive)

Microbiota

11th April to 18th of April

Prenatal Extended Panel Test

11th April to 18th of April

Neobona Test

14th April to 18th of April

Semen Sample

14th April to 18th of April

Telomere length

14th April to 18th of April

Catalase

14th April to 18th of April

Superoxide dismutase

14th April to 18th of April

STOCKHOLM3

11th April to 18th of April


We remind you that any test contained in the Personalized Medicine Catalog cannot be sent prior to a holiday.


In these most committed days, we kindly ask you to bear in mind the following stability information:

 TEST    

  ZONE

  SAMPLE

  CONSERVATION/

STABILITY
  

  FISH/ KARYOTYPE
 
 
 
 

 

  Prenatal

Chorionic villus

24-48h Room temperature
 3 days refrigerated

Amniotic fluid

24-48h Room temperature
 3 days refrigerated

Fetal blood

 24-48h Room temperature
 3 days refrigerated

 
 Abortive tissue
 

24-48h Room temperature
3 days refrigerated

  Postnatal

 Peripheral blood

 24-48h Room temperature
 4 days refrigerated

Skin biopsy

 24-48h Room temperature
 3 days refrigerated

  Hematological 

Peripheral blood

 24-48h Room Temperature

 Bone marrow

 24-48h Room Temperature

Ganglion biopsy or aspirated

24-48h Room Temperature
































As of  Tuesday, April 19th, the reception and processing of samples will be normalized.

If any doubt do not hesitate in contact us.

FILARIASIS ANTIBODIES, SERUM

Delivery Time Modification

Test code: 3142

Effective update from 06/04/2022




PREVIOUS

NEW

           
      Delivery term: 9 days
     
              
     
      Delivery term: 6 days
     
     

   Find the record of the test by clicking here

IgE SPECIFIC ANTIBODIES FOR DOG EPITHELIUM (e2) , SERUM

Delivery Time Modification

Test code: 465

Effective update from 06/04/2022


PREVIOUS

NEW

     
      Delivery term: 5 days
     
     
     
      Delivery term: 2 days
     
     
    

   Find the record of the test by clicking here

Wednesday, March 30, 2022

ANTI HEPARIN ANTIBODIES - PF4, PLASMA

Delivery Time Modification

Test code: 3282

Effective update from 05/04/2022




PREVIOUS

NEW
        
      
     
      Delivery term: 5 days
     
     

     

        
          
     
      Delivery term: 6 days
     
     

     

   Find the record of the test by clicking here

MANGANESIUM AND ALUMINUM, SERUM

Test Reactivated


Test code: 380/ 275
Nemonic code: MN / ALU
Effective update from 01/04/2022

Dear collegues and collaborators,

As we have previously informed you, due to problems arising from the manufacturing process of metal-free serum tubes from the commercial company VACUTEST, we were forced to discontinue the determinations of Aluminum (ALU) and Manganese (MN) upon detecting that, in certain manufacturing batches, the concentration of some of the trace elements present in them was higher than the permitted concentration.

As a temporary alternative to these tubes, the metal-free tube (Monovette Trace Metal Analysis) will be used, with reference 6000069082.
 
Said tube must be used exclusively for determinations of Aluminum and Manganese in serum. The tests will be reactivated from next April 1.
 
In order to properly manage the stock of these tubes, and since it is a temporary alternative, the request for these tubes must be made to the email customer.serviceinternational@synlab.es or customer.service@synlab.es

The quantity to be requested must be made by units, only counting on the demand that will be produced in the next month of April (quantities for stock greater than 50 units will not be served).



For the rest of the metals in serum, the same VACUTEST tube used to date should continue to be used, with reference 6000049270.

We remain at your disposal for any clarification.

XILOSE (XILOSE TEST), URINE

Result format Modification

Test code: 420

Effective update from 01/04/2022




PREVIOUS

NEW
   R1: Result (g/5H)



   Version of test: 12
     
     

   R1: Result (g/5H)
   R2: Concentration(mg/mL) 


   Version of test: 13

   Find the record of the test by clicking here

ENDOMETRIUM BASIC, NEOPLASM · PANEL · NGS

New Test in NOƛS Catalog

Test Code: 9544

Sample:
Tissue
Conservation:
Room temperature
Method:
Next Generation Sequencing (NGS)
Set Up Days:
Daily
Delivery term:
12 days

    Find the record of the test by clicking here

MAMMARY CARCINOME - EXTENDED · PANEL · NGS + FISH

New Test in NOƛS Catalog

Test Code: 9543

Sample:
Tissue
Conservation:
Room temperature
Method:
Next Generation Sequencing (NGS) + FISH
Set Up Days:
Daily
Delivery term:
12 days

    Find the record of the test by clicking here

PANCREAS, NEOPLASIA · PANEL · NGS

Description Modification

Test code: 8910
Mnemonic code: G15124
Effective update from 04/04/2022




PREVIOUS

NEW
  PANCREAS, NEOPLASIA · PANEL · NGS
     

      Version of Test: 20
     

  PANCREAS BASIC, NEOPLASIA · PANEL · NGS
     

      Version of Test:21
     

   Find the record of the test by clicking here

Monday, March 28, 2022

ONCO IN BLOOD · BRAF, KRAS, NRAS · NGS

New Test in NOƛS Catalog

Test Code: 9542

Sample:
SERUM + PLASMA EDTA(3mL)
Conservation:
Frozen
Method:
Next Generation Sequencing (NGS)
Set Up Days:
Daily
Delivery term:
12 days

    Find the record of the test by clicking here

VITAMIN B6 (PYRIDOXAL PHOSPHATE), TOTAL BLOOD

Transoceanic Sample Conservation Modification

Test code: 2023

Effective update from 31/03/2022




PREVIOUS

NEW
        
Frozen Whole Blood EDTA      
     

        
Refrigerated Whole Blood EDTA (Stability: 7 days)         


   Find the record of the test by clicking here

ONCOLOGY ACTIONABLE PANEL · PANEL · NGS

Studied Genes Modification

Test code: 8629

Effective update from 31/03/2022




PREVIOUS

NEW
AKT1, ALK, AR, ARAF, ATM, BRAF, BRCA1, BRCA2, CDKN2A, DDR2, EGFR, ERBB2, ERBB3, ESR1, FGFR3, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MET, MTOR, NF1, NRAS, PDGFRA, PIK3CA, PTCH1, PTEN, RET, ROS1, SMARCB1, TP53, TSC1, TSC2           
     
Version of Test: 30
     

AKT1, ALK, AR, ARAF, ARID1A, ATM, BRAF, BRCA1, BRCA2, CDKN2A, DDR2, EGFR, ERBB2, ERBB3, ESR1, FGFR3, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MET, MTOR, NF1, NRAS, PDGFRA, PIK3CA, POLE, PTCH1, PTEN, RET, ROS1, SMARCB1, TERTprom, TP53, TSC1, TSC2                         
Version of Test: 31
     

   Find the record of the test by clicking here

SUBFRACTION LDL CHOLESTEROL, SERUM

New Test in NOƛS Catalog

Test Code: 9539

Sample:
Serum (1 ml)
Conservation:
Refrigerated
Method:
Electrophoresis
Set Up Days:
Daily
Delivery term:
9 days

    Find the record of the test by clicking here

Friday, March 25, 2022

Technical Specifications Modification

Reference values Modification

Effective update from 29/03/2022


Test code

Description

Previous Reference Values

New Reference Values

684

Karyotype, total blood

Technique: Cell culture stimulated with PHA (phytohemagglutinin). Identification by G bands (ISCN 2016).
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size and discrepancies between tissues.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture for 48-72 hours stimulated with PHA (phytohemagglutinin). G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 15.

Limitations: This result does not include chromosomal findings interpreted as normal variants (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of analysis. studies, such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities and discrepancies between tissues.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

907

Karyotype, amniotic fluid

Technique: Cell culture. Analysis of two independent cultures. Identification by G bands (ISCN 2016).
 
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size, discrepancies between tissues and maternal cell contamination.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture. Analysis of two independent cultures. G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 20.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities, discrepancies between tissues and contamination with maternal cells.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

1016

Karyotype haematological, bone marrow

Technique: Cell culture (24 hours without stimulation and/or 72 hours stimulated with TPA (tetradecanoylphorbol acetate) or PHA (phytohaemagglutinin), according to diagnostic orientation). Identification by G bands (ISCN 2016).
 
Limitations: The present result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies. , mainly the absence of growth of pathological cells, the possible non-detection of some mosaics and small structural alterations.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture (24 hours without stimulation and/or 72 hours stimulated with TPA (tetradecanoylphorbol acetate) or PHA (phytohemagglutinin), depending on diagnostic orientation). G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 20.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. , mainly the absence of growth of pathological cells, the possible non-detection of some mosaics and small structural alterations.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

2260

Karyotype, tissue

Technique: Cell culture. Identification by G bands (ISCN 2016).
 
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size, discrepancies between tissues and maternal cell contamination.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture. G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 15.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities, discrepancies between tissues and contamination with maternal cells.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

2533

Karyotype, total cord blood

Technique: Cell culture (48h and 72h) stimulated with PHA (phytohemagglutinin). Identification by G bands (ISCN 2016).
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size, discrepancies between tissues and maternal cell contamination.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture for 48-72 hours stimulated with PHA (phytohemagglutinin). G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 15.

Limitations: This result does not include chromosomal findings interpreted as normal variants (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of analysis. studies, such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities and discrepancies between tissues.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

4479

Karyotype haematological, whole blood

Technique: Cell culture. Analysis of two independent cultures. Identification by G bands (ISCN 2016).
 
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size, discrepancies between tissues and maternal cell contamination.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture (24 hours without stimulation and/or 72 hours stimulated with TPA (tetradecanoylphorbol acetate) or PHA (phytohemagglutinin), depending on diagnostic orientation). G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 20.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. , mainly the absence of growth of pathological cells, the possible non-detection of some mosaics and small structural alterations.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

5446

Karyotype, fibroblasts

Technique: Cell culture. Identification by G bands (ISCN 2016).
 
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size, discrepancies between tissues and maternal cell contamination.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture. G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 15.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities, discrepancies between tissues and contamination with maternal cells.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

9605

Karyotype, culture

Technique: Cell culture stimulated with PHA (phytohemagglutinin). Identification by G bands (ISCN 2016).
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size and discrepancies between tissues.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture for 48-72 hours stimulated with PHA (phytohemagglutinin). G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 15.

Limitations: This result does not include chromosomal findings interpreted as normal variants (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of analysis. studies, such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities and discrepancies between tissues.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

2746

Karyotype, chorionic villus (culture + QF-PCR)

Additional IMAGE  is attached.
 
* NOTE: This study does not include findings interpreted as variants of normal
and is subject to the reservations to this type of analysis, primarily,
non-detection of some types of mosaics, small structural changes, the
contamination of cultures with maternal cells and feto-placental discrepancies.

Technique: Cell culture. Analysis of two independent cultures. G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 20.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities, discrepancies between tissues and contamination with maternal cells.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.

3474

Karyotype, chorionic villus (culture)

Technique: Cell culture. Analysis of two independent cultures. Identification by G bands (ISCN 2016).
Limitations: The present result does not include the chromosomal findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of studies, such as, among others, the presence of certain situations in mosaic, chromosomal anomalies of small size, discrepancies between tissues and maternal cell contamination.
For the interpretation of this type of analysis, it is recommended to attach the relevant clinical data of the patient and/or related relatives.
This report should be interpreted within the clinical context of the patient and according to medical criteria.

Technique: Cell culture. Analysis of two independent cultures. G-Banded Chromosomal Analysis (2020). Resolution level: 400-550 bands. Minimum number of metaphases studied: 20.

Limitations: This result does not include the findings interpreted as variants of normality (European Cytogeneticists Association (ECA) http://www.eca.eu/EN/GUIDELINES.html) and is subject to the limitations of this type of study. such as, among others, the presence of certain mosaic situations, small chromosomal abnormalities, discrepancies between tissues and contamination with maternal cells.
This report must be accompanied by the image of the corresponding karyotype and must be interpreted within the clinical context of the patient and according to medical criteria.